Clover Corporation Limited (CLV) AI Stock Analysis

• Market Cap: AU$131.09M
• Dividend Yield: 2.19%
• Average Volume (3M): 223.73K
• Price to Earnings (P/E): 18.6
• Beta (1Y): -0.23
• Revenue Growth: 38.25%
• EPS Growth: 361.54%
• Country: AU
• Employees: 60
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Packaged Foods
• EPS (TTM): 0.03
• Shares Outstanding: 166,999,340
• 10 Day Avg. Volume: 49,116
• 30 Day Avg. Volume: 223,729
• PEG Ratio: 0.04
• Price to Book (P/B): 1.28
• Price to Sales (P/S): 1.08
• P/FCF Ratio: 13.34
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): 0.05
• Revenue Forecast (FY): AU$89.40M

• Rating: 74 Outperform
• Price Target: AU$0.81 ▲(0.75% Upside)
• Action: Reiterated Date: 11/21/25
• Date: Action: Reiterated 11/21/25

Clover Corporation Limited has a strong financial foundation with robust revenue growth and profitability. The technical indicators suggest bullish momentum, though caution is advised due to overbought signals. The valuation is fair, providing a balanced risk-reward profile.

Positive Factors

Proprietary packaging IP

Clover's proprietary liquid-packaging designs and IP create durable differentiation in specialty dispensing. Intellectual property and product engineering act as barriers to entry, supporting sustained customer relationships, licensing potential and export growth over the next several quarters.

Strong revenue and profit margins

Consistent revenue expansion with healthy gross and improving net margins demonstrates effective cost control and scalable unit economics. These margin levels and 12.42% EBIT/14.23% EBITDA suggest structural profitability that can sustain reinvestment and support earnings durability.

Very low leverage and strong equity base

Extremely low leverage and a high equity ratio give Clover financial flexibility and resilience to shocks. A conservative capital structure reduces refinancing risk, supports investment across export markets, and preserves balance-sheet capacity for strategic initiatives.

Negative Factors

Free cash flow decline

A >60% drop in free cash flow growth is a durable operational cash concern: even with solid reported profits, weakening FCF constrains capital allocation, limits reinvestment or dividends, and may force financing or slowed strategic execution if the trend persists.

Modest return on equity

ROE under 10% signals only moderate efficiency in converting equity into returns. With a conservative capital structure, improving shareholder returns may require either faster profit growth or higher leverage, both of which are non-trivial strategic shifts and present long-term trade-offs.

Small scale and outsourcing reliance

A small headcount and reliance on outsourced manufacturing can limit control over costs, quality and capacity. Scaling export and industrial contracts may be constrained by third-party partners and supply-chain risk, creating a structural growth and margin vulnerability.

Clover Corporation Limited Business Overview & Revenue Model

Company Description

Clover Corporation Limited refines and sells natural oils in Australia, New Zealand, Asia, Europe, and the Americas. It also engages in the production of encapsulated products; and research and product development of functional food and infant nutrition ingredients. In addition, the company offers Nu-Mega Hi docosahexaenoic tuna oils for use in infant formula and pharmaceutical products; Ocean Gold refined tuna oils; Nu-Mega Driphorm powders that are used in a range of infant formula, follow-on formula, growing up milks, and food applications; and Nu-Mega Driphorm HA for non-dairy applications. Further, it provides products in the areas of active living-immune system and sports, healthy living–brain and heart, and starting out-infant and child. The company was incorporated in 1988 and is headquartered in Altona North, Australia.

How the Company Makes Money

Clover Corporation generates revenue through the sale of its food ingredient products, particularly natural colorants and flavor enhancers. The company’s revenue model is based on direct sales to food manufacturers and distributors, which allows it to reach a broad customer base across various segments including confectionery, dairy, and beverages. Key revenue streams include bulk sales of colorants, customized formulations for specific customer needs, and ongoing research and development collaborations with industry partners. Additionally, Clover may benefit from strategic partnerships with larger food companies that seek to enhance their product offerings with natural ingredients, further contributing to its earnings.

Clover Corporation Limited Financial Statement Overview

Summary

Clover Corporation Limited shows strong financial health with impressive revenue growth and profitability margins. The balance sheet is robust with low leverage, enhancing financial stability. However, the significant decline in free cash flow growth could pose a risk if not addressed.

Income Statement

Clover Corporation Limited has demonstrated strong revenue growth of 18.64% in the latest year, with improving gross profit and net profit margins at 30.43% and 8.16%, respectively. The EBIT and EBITDA margins also show a healthy profitability trend at 12.42% and 14.23%. This indicates a robust financial performance with effective cost management and operational efficiency.

Balance Sheet

The company's balance sheet is solid with a low debt-to-equity ratio of 0.03, indicating minimal leverage and financial risk. The return on equity is 9.71%, reflecting decent profitability relative to shareholder equity. The equity ratio stands at 83.23%, showcasing a strong capital structure with significant equity backing.

Cash Flow

While the operating cash flow to net income ratio is healthy at 0.65, indicating good cash generation relative to earnings, the free cash flow growth has declined by 62.47%. The free cash flow to net income ratio of 0.84 suggests that the company is generating sufficient cash to cover its net income, but the decline in free cash flow growth is a concern.

Breakdown	Jul 2025	Jul 2024	Jul 2023	Jul 2022	Jul 2021
Income Statement
Total Revenue	86.00M	62.21M	79.88M	70.66M	60.51M
Gross Profit	26.17M	16.86M	23.74M	21.66M	18.24M
EBITDA	12.24M	3.98M	10.01M	11.66M	10.23M
Net Income	7.01M	1.51M	6.21M	7.13M	6.00M
Balance Sheet
Total Assets	86.80M	84.39M	86.20M	90.77M	78.73M
Cash, Cash Equivalents and Short-Term Investments	8.68M	12.26M	9.44M	10.11M	9.09M
Total Debt	2.42M	10.39M	11.71M	12.08M	14.19M
Total Liabilities	14.57M	17.32M	19.05M	27.73M	20.32M
Stockholders Equity	72.23M	67.07M	67.15M	63.04M	58.42M
Cash Flow
Free Cash Flow	6.95M	6.13M	5.10M	4.51M	6.40M
Operating Cash Flow	8.29M	8.45M	6.74M	5.93M	8.23M
Investing Cash Flow	-1.34M	-2.97M	-2.53M	-1.43M	-1.83M
Financing Cash Flow	-10.52M	-2.66M	-4.88M	-3.49M	-6.55M

Clover Corporation Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.80
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:CLV, the sentiment is Positive. The current price of 0.8 is above the 20-day moving average (MA) of 0.76, above the 50-day MA of 0.78, and above the 200-day MA of 0.64, indicating a bullish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 54.56 is Neutral, neither overbought nor oversold. The STOCH value of 82.53 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:CLV.

Clover Corporation Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLV	74 Outperform	AU$131.09M	18.57	10.07%	2.19%	38.25%	361.54%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BUB	59 Neutral	AU$107.30M	28.57	13.97%	―	28.66%	―
NUC	45 Neutral	AU$21.17M	-4.43	-29.43%	―	102.21%	69.47%
NGS	43 Neutral	AU$6.66M	-0.61	―	―	-21.84%	79.99%
HCT	41 Neutral	AU$25.75M	-26.92	―	―	6.76%	―
AHF	40 Underperform	AU$26.88M	-5.25	-20.54%	―	13.92%	36.28%

Clover Corporation Limited Corporate Events

Clover Distances Itself from ARA Oil Contamination Behind Infant Formula Recalls

Clover Corporation Limited has moved to reassure the market that its products are not implicated in recent infant formula recalls linked to contamination in a batch of ARA (Arachidonic Acid) oil supplied by an unrelated third party. The company said routine quality controls and additional targeted testing confirm its products remain safe, fully compliant and unaffected, and stressed it has no sourcing, supply, commercial or technical ties to the supplier involved. Clover remains fully operational with uninterrupted supply, and is actively working with customers on alternative formulations, supply continuity and protecting product stability and brand trust, positioning itself as a reliable partner amid sector disruption.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Launches Employee Share Scheme Buy-Back

Clover Corporation Limited has announced an employee share scheme buy-back of its ordinary fully paid shares, indicating a capital management initiative focused on its staff equity programs. The move is expected to refine the company’s share structure by repurchasing shares issued under employee schemes, which may have implications for share dilution and aligns with ongoing efforts to align employee incentives with shareholder interests.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation to On-Market Buy Back Shares for Employee Plan

Clover Corporation has instructed the trustee of its Employee Share Plan Trust to acquire up to 3,264,167 fully paid ordinary shares on-market over a period of up to 24 months to satisfy potential future vesting of Performance Rights granted between 2024 and 2026. The on-market buyback, representing 1.95% of the company’s issued capital, is intended to meet employee equity obligations without issuing new shares, thereby limiting shareholder dilution, and will be executed under defined pricing, timing and compliance parameters aligned with ASX listing rules and Australian corporations law.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Announces Director’s Change in Securities Holdings

Clover Corporation Limited announced a change in the director’s interest, specifically involving Peter Davey. The change reflects an increase in the number of performance rights held directly by the director, with 529,638 performance rights acquired and 255,199 disposed of, resulting in a total of 1,361,706 performance rights held. This adjustment in holdings may indicate strategic positioning or confidence in the company’s future performance, potentially impacting stakeholders’ perceptions and the company’s market positioning.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation’s AGM Approves Key Resolutions for Strategic Growth

Clover Corporation Limited held its Annual General Meeting on November 18, 2025, where several key resolutions were passed. The shareholders approved the adoption of the remuneration report, re-elected Dr. Simon Green and elected Ms. Fiona Pearse as directors, approved the acquisition of performance rights for the Managing Director, endorsed the long-term incentive plan, and adopted a new constitution. These decisions reflect the company’s strategic focus on governance and incentive alignment, potentially impacting its operational efficiency and stakeholder engagement positively.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.

Clover Corporation Reports Strong FY25 Performance and Strategic Growth Initiatives

Clover Corporation Limited reported a strong financial year in FY25, marked by a significant increase in sales and improved financial performance due to a successful diversification strategy. The company achieved notable milestones, including the commissioning of a fish oil extraction facility in Ecuador and the first full year of profit at Melody Dairies. The company is poised for further growth through its new distributor model and the promising CholineXcel project, targeting infant and prenatal nutrition markets, while continuing to explore opportunities in high-value nutraceutical markets.

The most recent analyst rating on (AU:CLV) stock is a Buy with a A$1.00 price target. To see the full list of analyst forecasts on Clover Corporation Limited stock, see the AU:CLV Stock Forecast page.